Healthlead Public Company Limited
Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies, and medical devices, as well as disinfectant and deodorizing products comprising mask products under the iCare, Pharmax, vitaminclub, … Read more
Healthlead Public Company Limited (HL) - Net Assets
Latest net assets as of September 2025: ฿973.06 Million THB
Based on the latest financial reports, Healthlead Public Company Limited (HL) has net assets worth ฿973.06 Million THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿1.50 Billion) and total liabilities (฿527.40 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿973.06 Million |
| % of Total Assets | 64.85% |
| Annual Growth Rate | 42.1% |
| 5-Year Change | 704.86% |
| 10-Year Change | N/A |
| Growth Volatility | 204.31 |
Healthlead Public Company Limited - Net Assets Trend (2017–2024)
This chart illustrates how Healthlead Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Healthlead Public Company Limited (2017–2024)
The table below shows the annual net assets of Healthlead Public Company Limited from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿1.01 Billion | +3.90% |
| 2023-12-31 | ฿968.05 Million | +2.77% |
| 2022-12-31 | ฿941.99 Million | +8.79% |
| 2021-12-31 | ฿865.89 Million | +592.88% |
| 2020-12-31 | ฿124.97 Million | +15.61% |
| 2019-12-31 | ฿108.09 Million | +25.21% |
| 2018-12-31 | ฿86.33 Million | +0.45% |
| 2017-12-31 | ฿85.94 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Healthlead Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 19569618800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿186.43 Million | 18.54% |
| Other Components | ฿819.39 Million | 81.46% |
| Total Equity | ฿1.01 Billion | 100.00% |
Healthlead Public Company Limited Competitors by Market Cap
The table below lists competitors of Healthlead Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Emperor Entertainment Hotel Limited
F:EM7A
|
$14.11 Million |
|
Cleanspace Holdings Ltd
AU:CSX
|
$14.11 Million |
|
Techbond Group Bhd
KLSE:5289
|
$14.12 Million |
|
Alpha Microelectronics
TWO:8024
|
$14.12 Million |
|
Cogra 48 Société Anonyme
PA:ALCOG
|
$14.10 Million |
|
IDP Corp Ltd.
KQ:332370
|
$14.10 Million |
|
Thong Nhat Rubber JSC
VN:TNC
|
$14.10 Million |
|
Shui-Mu International Co Ltd
TW:8443
|
$14.10 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Healthlead Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 968,050,697 to 1,005,823,925, a change of 37,773,228 (3.9%).
- Net income of 78,264,188 contributed positively to equity growth.
- Dividend payments of 40,799,985 reduced retained earnings.
- Other comprehensive income decreased equity by 13,600,000.
- Other factors increased equity by 13,909,025.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿78.26 Million | +7.78% |
| Dividends Paid | ฿40.80 Million | -4.06% |
| Other Comprehensive Income | ฿-13.60 Million | -1.35% |
| Other Changes | ฿13.91 Million | +1.38% |
| Total Change | ฿- | 3.90% |
Book Value vs Market Value Analysis
This analysis compares Healthlead Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.80x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 12.38x to 1.80x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ฿0.54 | ฿6.65 | x |
| 2018-12-31 | ฿0.32 | ฿6.65 | x |
| 2019-12-31 | ฿0.40 | ฿6.65 | x |
| 2020-12-31 | ฿0.46 | ฿6.65 | x |
| 2021-12-31 | ฿4.20 | ฿6.65 | x |
| 2022-12-31 | ฿3.46 | ฿6.65 | x |
| 2023-12-31 | ฿3.56 | ฿6.65 | x |
| 2024-12-31 | ฿3.70 | ฿6.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Healthlead Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.78%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.96%
- • Asset Turnover: 1.32x
- • Equity Multiplier: 1.49x
- Recent ROE (7.78%) is below the historical average (11.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -10.78% | -1.32% | 2.53x | 3.23x | ฿-17.86 Million |
| 2018 | 0.45% | 0.05% | 3.22x | 2.81x | ฿-8.24 Million |
| 2019 | 20.14% | 2.40% | 3.06x | 2.74x | ฿10.96 Million |
| 2020 | 41.67% | 4.89% | 2.67x | 3.19x | ฿39.58 Million |
| 2021 | 9.20% | 6.65% | 1.07x | 1.29x | ฿-6.92 Million |
| 2022 | 12.55% | 7.78% | 1.18x | 1.37x | ฿24.03 Million |
| 2023 | 7.71% | 4.57% | 1.18x | 1.43x | ฿-22.13 Million |
| 2024 | 7.78% | 3.96% | 1.32x | 1.49x | ฿-22.32 Million |
Industry Comparison
This section compares Healthlead Public Company Limited's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $74,477,637
- Average return on equity (ROE) among peers: 34.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Healthlead Public Company Limited (HL) | ฿973.06 Million | -10.78% | 0.54x | $14.11 Million |
| E for L Aim Public Company Limited (EFORL) | $-104.57 Million | 0.00% | 0.00x | $13.47 Million |
| SEI (SEI) | $28.36 Million | 62.98% | 8.85x | $3.29 Million |
| SaintMed Public Company Limited (SMD) | $135.64 Million | 40.21% | 2.49x | $11.69 Million |
| Techno Medical Public Company Limited (TM) | $222.40 Million | 20.33% | 1.97x | $2.99 Million |
| Winnergy Medical Public Company Limited (WINMED) | $90.56 Million | 49.99% | 2.66x | $3.06 Million |